Targeted Agents and Resistance Mechanism in Renal Cell Cancer

Journal Title: Üroonkoloji Bülteni - Year 2019, Vol 18, Issue 2

Abstract

Renal cell carcinoma (RCC) exhibits multidrug resistance protein P-glycoprotein expression due to the proximal tubular origin and in this regard, it is resistant to a large number of cytotoxic chemotherapy. The identification of the molecular pathogenesis, genetics, and epigenetics of RCC has led to new target points such as vascular endothelial growth factor. Tyrosine kinase inhibitors have been used mainly for treatment, but recently, immune checkpoint inhibitors have also been used in the treatment of RCC. Despite these treatments, response rates are not sufficient in the majority of patients. Primary resistance or acquired resistance to the treatment might be seen. Defining these resistance mechanisms will contribute to the management of the treatment and will help in to identify new treatment targets. In this review, we focus on the molecular mechanisms and resistance mechanisms of targeted-therapy.

Authors and Affiliations

Shaghayegh Rezapourbehnagh, Hatime Arzu Yaşar, Çağatay Arslan, Yüksel Ürün

Keywords

Related Articles

The Diagnostic and Prognostic Significance of MicroRNA-21 in Non-muscle Invasive Bladder Tumors

Bladder cancer (BC) is one of the commonly diagnosed urological cancers that causes human death, ranked as the seventh most common cancer worldwide. To date, no reliable diagnostic tool has been defined to recognize non-...

Social Awareness on Early Diagnosis and Treatment of Bladder Cancer: Importance of Age and Education

Objective: We aimed to evaluate the recognition level of bladder cancer in the society by conducting a survey with regards to social awareness in early diagnosis of bladder cancer in this study. Materials and Methods: T...

Retroperitoneal Inflammatory Myofibroblastic Tumor: A Rare Case Report and Literature Review

Primary retroperitoneal inflammatory myofibroblastic tumors (IMT) are a very rare clinical condition. Herein, we present a case of IMT in the retroperitoneal area. A 52-year-old woman presented with abdominal lump and ex...

Tamsulosin Can Improve Lower Urinary Tract Symptoms in Patients Under Active Surveillance Due to Low Risk Prostate Cancer: Prospective Controlled Study

Objective: We aimed to evaluate the efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in patients under active surveillance (AS) for low-risk prostate cancer (Pca). Materials and Methods: Pat...

Is Anterior Exenteration Necessary in Women Undergoing Radical Cystectomy?

Objective: Radical cystectomy is the gold standard for the treatment of muscle-invasive bladder cancer. Anterior exenteration with cystectomy is standard practice in female patients. In this study, we aimed to evaluate t...

Download PDF file
  • EP ID EP588923
  • DOI 10.4274/uob.galenos.2018.1090
  • Views 91
  • Downloads 0

How To Cite

Shaghayegh Rezapourbehnagh, Hatime Arzu Yaşar, Çağatay Arslan, Yüksel Ürün (2019). Targeted Agents and Resistance Mechanism in Renal Cell Cancer. Üroonkoloji Bülteni, 18(2), 73-79. https://europub.co.uk/articles/-A-588923